FDA’s Schwartz Says New Draft Cybersecurity Guidance Addresses Emerging Threats

Agency shifts focus to software, removes tiered risk assessments

 
• By Brian Bossetta
  
Suzanne Schwartz is director of the Office of Strategic Partnerships & Technology Innovation at the Center for Devices & Radiological Health.
SUZANNE SCHWARTZ • Source: FDA
Medtech Insight Podcast

Keep up with the top medtech business and regulatory news.

Medtech Insight brings you interviews and analysis, on the go.

SpotifyApple PodcastsWebsite

More from Regulation

More from Policy & Regulation